Review of Systemic Immunosuppression for Autoimmune Uveitis

Claudia Castiblanco, C. Stephen Foster

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations


The purpose of this review is to comprehensively examine the various therapeutic agents available to treat autoimmune eye disease, their indications, clinical safety and recent developments. The stepladder approach is reviewed, including corticosteroid administration of various forms, classic immunomodulators, and newer biologic response modifiers. The authors present that corticosteroid monotherapy is almost never curative and carries significant side effects, while immunomodulatory therapy, when used appropriately as way to induce steroid-free remission, carries far less risk of causing long-term complications and provides greater potential of altering the immune system to induce a durable remission.

Original languageEnglish (US)
Pages (from-to)17-36
Number of pages20
JournalOphthalmology and Therapy
Issue number1-2
StatePublished - Dec 4 2014
Externally publishedYes


  • Corticosteroid
  • Immunomodulatory therapy
  • Inflammation
  • Ophthalmology
  • Uveitis

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Review of Systemic Immunosuppression for Autoimmune Uveitis'. Together they form a unique fingerprint.

Cite this